Tolerable and curable treatment in HIV/HCV co-infected patients using anti-HCV direct antiviral agents: a real-world observation in China-Reference-Cited by-同舟云学术

Tolerable and curable treatment in HIV/HCV co-infected patients using anti-HCV direct antiviral agents: a real-world observation in China

Published:2018-09 Issue:5 Volume:12 Page:465-473
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Li Yuanyuan,Li Linghua,Liu Jun,Zhang Da-Wei,Zhao Fang,Wang Li,Mahemure Aizezi.,Xie Ronghui,Lei Suyun,Cai Weiping,Wang Xicheng,Shu Zhanjun,Chen Xiejie,Wang Hui,Wang Fu-Sheng

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/article/10.1007/s12072-018-9891-9/fulltext.html

Reference24 articles.

1. Panel AIHG. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology 2015;62(3):932–954. https://doi.org/10.1002/hep.27950

2. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis 2005;192(6):992–1002. https://doi.org/10.1086/432762

3. Chen TY, Ding EL, Seage Iii GR, Kim AY. Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression. Clin Infect Dis 2009;49(10):1605–1615. https://doi.org/10.1086/644771

4. Data Collection on Adverse Events of Anti HIVdSG, Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, et al. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A: D Study. AIDS 2010;24(10):1537–1548. https://doi.org/10.1097/qad.0b013e32833a0918

5. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000;356(9244):1800–1805

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decreased Efficacy of Sofosbuvir/Velpatasvir in HIV Patients Coinfected with HCV Genotype 3b;Future Virology;2024-01

2. Characterizing Persons With HIV/HCV Coinfection Who Remain Untreated for Hepatitis C at Four HIV Clinics in Connecticut (CT): Role of Multiple Overlapping Barriers at the Individual and Clinic System Levels;Health Promotion Practice;2023-07-13

3. Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort study;Health Science Reports;2023-02

4. Transmission networks of hepatitis C virus among HIV/HCV-coinfected patients in Guangdong, China;Virology Journal;2022-07-14

5. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections;World Journal of Gastroenterology;2022-03-21